Ultrasound for measuring plaque psoriasis severity
Part of Skin clinical trials.
This study uses a special ultrasound technique to get a better measure of how severe your plaque psoriasis is. It aims to see if this imaging can help doctors track the disease more accurately.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with plaque psoriasis by a doctor.
- You are willing to take part in the study and sign a consent form.
- You do not have another type of psoriasis (like guttate or pustular).
- You do not have any other active medical conditions that could affect results.
- You do not have a severe infection that is not under control.
- You do not have a serious mental illness or cognitive condition that would prevent participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication called ICP-332 versus a placebo (a pill with no active drug) for people with moderate to severe plaque psoriasis. The goal is to see if ICP-332 can improve skin symptoms and be safe.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This study looks at how people with plaque psoriasis manage their condition and follow treatment plans. It aims to understand what helps or hinders participation, so researchers can improve care for others like you.
This study tests a new oral pill (HSK47388) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective in reducing the severity and area of psoriasis over 12 weeks.
This trial tests a new study drug (ZP9830) to see if it is safe and works well for people with plaque psoriasis. You would receive the treatment for 8 weeks, and the study will check how your skin responds.
This study tests an investigational oral medication called HS-10374 for moderate to severe plaque psoriasis. It aims to see how well it clears skin and prevents flares compared to a placebo, and if it is safe for long-term use.
Hear when a new Plaque Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.